"{{ovation.quote}}"
-{{ovation.company}}
Drug Shortages in the U.S.
Desperate patients, massive shortages, and counterfeit semaglutide drugs have been top of mind for investigative journalist KATHERINE EBAN lately. From Ozempic pens smuggled stateside to investigations into Wuhan’s lab leak, Eban gives audiences a bird’s eye view of the global events impacting us today.
Pharmaceutical Integrity
This talk, based on KATHERINE EBAN's book Dangerous Doses, describes how weak laws and poorly-implemented regulations have allowed corrupt secondary wholesalers, and even counterfeiters, to infiltrate the U.S. drug supply. This talk can be adapted for medical professionals, drug manufacturers, pharmaceutical packagers or for any company trying to ensure that their products don’t get lost in a shadowy and lucrative grey market.
Are Generic Drugs Really Bioequivalent
Generic drugs now comprise 90% of the U.S. drug supply, and the FDA has claimed that they are interchangeable with brand-name drugs. But as patients, doctors and investigators have begun to discover, they differ – sometimes dangerously – in many ways. This talk, which will be of interest to patient and medical groups, KATHERINE EBAN will expose how generic drugs are actually evaluated, approved and regulated, and the hidden incentives for the companies making them to cut corners (or worse).
The Dark Side of Globalization
You may think that you see eye-to-eye with the manufacturers or partners making your products half-way around the world. But invisible country and business culture may matter more than careful contracts and routine inspections. This talk, enlivened by anecdotes, will take business and regulatory audiences into a world hidden from view: fake data, manipulated ingredients, and infestations of snakes and frogs. I can also discuss solutions for protecting ones products.
The Critical Importance and Power of Investigative Journalism
Renowned investigative journalist and New York Times bestselling author KATHERINE EBAN talks about the power and importance of investigative journalism. Her Vanity Fair articles - especially during the time of COVID-19 and the resulting public health and vaccination rollout - have won international attention and awards for finding and following the truth of the story. In her speeches, Katherine walks audiences through the critical importance of investigative journalism, how her stories have made a difference, and what Americans need to know to be better informed and safer.
Investigative journalist Katherine Eban investigates Ozempic
Investigative journalist KATHERINE EBAN, who has published multiple groundbreaking books on the pharmaceutical industry, has been highly sought after to speak on the impact of the current wave of semaglutide drugs hitting the market (such as Ozempic). After publishing a viral Vanity Fair article, Eban was recently invited on MSNBC to discuss the impact of counterfeit Ozempic in the U.S. drug supply. Eban told Morning Joe, “This is within the heart of our drug supply, which is supposed to be protected.”
New York Times Bestselling author and investigative journalist Katherine Eban uses her journalistic skills to engage audiences about public health
Renowned investigative journalist and New York Times Bestselling author Katherine Eban is an Andrew Carnegie fellow and Vanity Fair contributor. Her important articles- especially during the time of Covid and the resulting public health and vaccination rollout - have won international attention and numerous awards for finding and following the truth of the story. She has also written for Fortune Magazine, The New York Times, and other publications. Her work has been featured on 60 Minutes, Nightline, NPR, and other national news programs. Eban has written two books, Dangerous Doses and Bottle of Lies, found repeated success, becoming a New York Times Bestseller, named to the New York Times list of 100 Notable Books in 2019, the New York Public Library Best Books of 2019, the Kirkus Reviews Best Health and Science Books of 2019, and Science Friday Best Books of 2019.
In her speeches, Catherine walks audiences through the critical importance of investigative journalism, how her stories have made a difference, and what Americans need to know to be better informed and safer.
Read Catherine’s investigative journalism in Vanity Fair here >>
KATHERINE EBAN, an investigative journalist, is a Vanity Fair contributing editor and Andrew Carnegie fellow. Her articles on pharmaceutical counterfeiting, gun trafficking, and coercive interrogations by the CIA have won international attention and numerous awards. She has also written for Fortune Magazine, the New York Times and other publications. Her work has been featured on 60 Minutes, Nightline, NPR, and other national news programs. She lectures frequently on the topic of pharmaceutical integrity.
Her second book, Bottle of Lies: the Inside Story of the Generic Drug Boom (May 2019) was a New York Times bestseller. Based on a decade of reporting, the book takes readers deep into the overseas manufacturing plants where the majority of our low-cost generic medicine is made. It reveals endemic fraud and dire conditions in an industry where companies routinely falsify data and circumvent safe manufacturing practices to minimize cost and maximize profit.
Her first book, Dangerous Doses: a True Story of Cops, Counterfeiters and the Contamination of America’s Drug Supply, was named one of the Best Books of 2005 by Kirkus Reviews and was a Barnes & Noble Discover Great New Writers pick. Her work has also been awarded grants from the Alfred P. Sloan Foundation, the Fund for Investigative Journalism, the Alicia Patterson Foundation and the McGraw Center for Business Journalism at CUNY’s Craig Newmark Graduate School of Journalism.
Educated at Brown University and Oxford University, where she was a Rhodes Scholar, she lives in Brooklyn with her husband, two daughters and Newfoundland dog Romeo.
My Speaker List
